Forte Biosciences
FBRX • NASDAQ
Forte Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul A. Wagner, with a market cap of $360.9M.
CEOPaul A. Wagner
Market Cap$360.9M
Biotechnology
Healthcare
Employees11.0
Websitefortebiorx.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Forte Biosciences
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$1.28
Earnings History
Past 12 earnings reports for Forte Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.99Est: -$1.06 | +6.6% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.96Est: -$1.15 | +16.5% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$1.37 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$1.18Est: -$2.74 | +56.9% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$4.54Est: -$7.12 | +36.2% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$6.75Est: -$4.25 | -58.8% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$4.00 | — | - | — | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$1.00 | — | - | — | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$6.50 | — | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$10.50 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$8.00 | — | - | — | — |
| Mar 31, 2023 | Q4 2022 | -$6.00Est: -$4.00 | -50.0% | - | — | — |